Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 1/2 11Phase 3 4Phase NA 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3Lymphoid 1

Conditions

Multiple Myeloma 3Lymphoma, Non-Hodgkin 1

Interventions

Cisplatin 187Carboplatin 182Paclitaxel 177Docetaxel 145Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 82Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 48Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Has results × plerixafor × Clear all
NCT01146834 2019-12-27

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Weill Medical College of Cornell University

Phase 3 Completed
47 enrolled 12 charts
Plasma cell

Multiple Myeloma

NCT01301963 2014-08-06

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Case Comprehensive Cancer Center

Phase 3 Terminated
9 enrolled 7 charts
Plasma cell

Multiple Myeloma

NCT00103610 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

Sanofi

Phase 3 Completed
298 enrolled 16 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00103662 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients

Sanofi

Phase 3 Completed
302 enrolled 17 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡